Follow
Kartika Venugopal
Kartika Venugopal
Dana Farber Cancer Institute
No verified email
Title
Cited by
Cited by
Year
Recent advances in cellulosic membranes for gas separation and pervaporation
WJ Schell, CG Wensley, MSK Chen, KG Venugopal, BD Miller, JA Stuart
Gas Separation & Purification 3 (4), 162-169, 1989
691989
Development of membrane pervaporation TRIM™ process for methanol recovery from CH3OH/MTBE/C4 mixtures
MSK Chen, GS Markiewicz, KG Venugopal
AIChE Symp. Ser 85 (272), 82-88, 1989
611989
Activation of tumor-cell STING primes NK-cell therapy
EH Knelson, EV Ivanova, M Tarannum, M Campisi, PH Lizotte, MA Booker, ...
Cancer immunology research 10 (8), 947-961, 2022
292022
Alterations to DNMT3A in hematologic malignancies
K Venugopal, Y Feng, D Shabashvili, OA Guryanova
Cancer research 81 (2), 254-263, 2021
292021
DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks
K Venugopal, Y Feng, P Nowialis, H Xu, DE Shabashvili, CM Berntsen, ...
Clinical Cancer Research 28 (4), 756-769, 2022
102022
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
DE Shabashvili, Y Feng, P Kaur, K Venugopal, OA Guryanova
Experimental hematology 110, 20-27, 2022
42022
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
Y Feng, Q Yuan, RC Newsome, T Robinson, RL Bowman, AN Zuniga, ...
Journal of Experimental Medicine 220 (11), e20230011, 2023
32023
Dnmt3a mutations in the hematopoietic system promote colitis-associated colon cancer: A model of clonal hematopoiesis in solid tumors
Y Feng, R Newsome, T Robinson, RL Bowman, A Zuniga, K Hall, ...
Blood 138, 2161, 2021
32021
DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents
HLC Roman, K Venugopal, Y Feng, DE Shabashvili, LM Posada, J Li, ...
Leukemia research 94, 106372, 2020
32020
DNMT3A with leukemia-associated mutations directs sensitivity to DNA damage at replication forks
K Venugopal, DE Shabashvili, J Li, LM Posada, RL Bennett, Y Feng, ...
Blood 134, 535, 2019
12019
DNMT3A with Leukemia-Associated R882 Mutations Promotes Fitness Advantage through Functional Heterogeneity within HSCs
Z Zaroogian, C Gunaratne, D Shabashvili, C Berntsen, Y Feng, ...
Blood 138, 2151, 2021
2021
3141–LEUKEMIA-ASSOCIATED MUTATIONS IN DNMT3A MEDIATE SENSITIVITY TO REPLICATION STRESS INDUCED BY NUCLEOSIDE ANALOGS
K Venugopal, D Shabashvili, J Li, Y Feng, A Riva, S Pondugula, ...
Experimental Hematology 88, S82, 2020
2020
Cells with DNMT3A Mutations Are More Sensitive to Cytarabine-Induced DNA Damage
K Venugopal, J Li, DE Shabashvili, LM Posada, Y Feng, D Dupere-Richer, ...
Blood 132, 2643, 2018
2018
Targeting DNA replication as a therapeutic strategy for acute myeloid leukemia with DNMT3A mutations
K Venugopal, D Dupéré-Richer, J Licht, O Guryanova
Cancer Research 78 (13_Supplement), 343-343, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–14